Lonza | LONN - Operating Expenses


Lonza reported CHF2.9B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.34B 206M Jun/2026
Alcon AG USD 2.78B 370M Jun/2026
Almirall EUR 531.16M 13.76M Jun/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
BASF EUR 15.77B 1.16B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Demant DKK 10.79B 1.16B Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.32B 20.7M Jun/2026
Geberit CHF 581.3M 1.3M Dec/2025
Genmab DKK 748M 77M Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GN Store Nord DKK 2.11B 51M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 7.02B 1.81B Jun/2026
Merck EUR 4.34B 249M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Philips EUR 3.75B 147M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Sika AG CHF 4.8B 78.3M Dec/2025
Smith & Nephew USD 2.59B 71M Jun/2026
Solvay EUR 1.07B 44M Jun/2026
UCB EUR 2.96B 196M Dec/2025